Hanmi Pharmaceuticals, Co. Ltd. (128940):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Hanmi Pharmaceuticals, Co. Ltd. (128940) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH297367FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Hanmi Pharmaceuticals, Co. Ltd. (Hanmi Pharma) is a pharmaceutical products manufacturer. The company manufactures and supplies prescription drugs and over-the-counter (OTC) drugs. Its prescription drugs include antibiotics, osteoporosis, liver supplements and antiemetics. Hanmi Pharma offers OTC products such as vitamins, nutritional supplements and calcium supplement, among others. The company’s products are used in the treatment of cancer, depression, anti-inflammatory, antibiotic, cardiovascular, dementia, dermatology, diabetes, epilepsy, gastrointestinal, hepatitis, hypnotics, osteoarthritis, osteoporosis and others. It operates through its four manufacturing facilities including Hanmi Paltan plant, Hanmi Fine Chemical, Hanmi Cepha plant and Hanmi Bio plant. Hanmi Pharma is headquartered in Seoul, South Korea.

Hanmi Pharmaceuticals, Co. Ltd. Key Recent Developments

Dec 06, 2013: Pfizer Korea And Hanmi Pharmaceutical In Legal Battle Over Viagra Pill Design
Dec 02, 2013: Sanofi-Hanmi launches Robelito, the first ARB-Statin combination drug in Korea
Jul 05, 2013: Hanmi – Korea’s First EU GMP Endorsed Injectable Powder Antibiotic
May 16, 2013: Hanmi profit soars in Beijing
Mar 19, 2013: Hanmi Pharma Selects Medidata Clinical Cloud For Faster Data Capture And Better Operational Oversight Of Clinical Trials

This comprehensive SWOT profile of Hanmi Pharmaceuticals, Co. Ltd. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Hanmi Pharmaceuticals, Co. Ltd. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Hanmi Pharmaceuticals, Co. Ltd. – Key Information
Hanmi Pharmaceuticals, Co. Ltd. – Overview
Hanmi Pharmaceuticals, Co. Ltd. – Key Employees
Hanmi Pharmaceuticals, Co. Ltd. – Key Employee Biographies
Hanmi Pharmaceuticals, Co. Ltd. – Key Operational Heads
Hanmi Pharmaceuticals, Co. Ltd. – Major Products and Services
Hanmi Pharmaceuticals, Co. Ltd. – History
Hanmi Pharmaceuticals, Co. Ltd. – Company Statement
Hanmi Pharmaceuticals, Co. Ltd. – Locations And Subsidiaries
Hanmi Pharmaceuticals, Co. Ltd. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Hanmi Pharmaceuticals, Co. Ltd. – Business Description
Hanmi Pharmaceuticals, Co. Ltd. – Corporate Strategy
Hanmi Pharmaceuticals, Co. Ltd. – SWOT Analysis
SWOT Analysis – Overview
Hanmi Pharmaceuticals, Co. Ltd. – Strengths
Hanmi Pharmaceuticals, Co. Ltd. – Weaknesses
Hanmi Pharmaceuticals, Co. Ltd. – Opportunities
Hanmi Pharmaceuticals, Co. Ltd. – Threats
Hanmi Pharmaceuticals, Co. Ltd. – Key Competitors

Section 3 – Company Financial Performance Charts

Hanmi Pharmaceuticals, Co. Ltd. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Hanmi Pharmaceuticals, Co. Ltd., Key Information
Hanmi Pharmaceuticals, Co. Ltd., Key Ratios
Hanmi Pharmaceuticals, Co. Ltd., Share Data
Hanmi Pharmaceuticals, Co. Ltd., Major Products and Services
Hanmi Pharmaceuticals, Co. Ltd., History
Hanmi Pharmaceuticals, Co. Ltd., Key Employees
Hanmi Pharmaceuticals, Co. Ltd., Key Employee Biographies
Hanmi Pharmaceuticals, Co. Ltd., Key Operational Heads
Hanmi Pharmaceuticals, Co. Ltd., Other Locations
Hanmi Pharmaceuticals, Co. Ltd., Subsidiaries
Hanmi Pharmaceuticals, Co. Ltd., Key Manufacturing facilities
Hanmi Pharmaceuticals, Co. Ltd., Key Competitors
Hanmi Pharmaceuticals, Co. Ltd., SWOT Analysis
Hanmi Pharmaceuticals, Co. Ltd., Ratios based on current share price
Hanmi Pharmaceuticals, Co. Ltd., Annual Ratios
Hanmi Pharmaceuticals, Co. Ltd., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Hanmi Pharmaceuticals, Co. Ltd., Performance Chart
Hanmi Pharmaceuticals, Co. Ltd., Ratio Charts

★海外企業調査レポート[Hanmi Pharmaceuticals, Co. Ltd. (128940):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NiSource Inc.:企業の戦略・SWOT・財務分析
    SummaryNiSource Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Xencor, Inc. (XNCR)(製薬・医療分野):企業M&A動向
    Summary Xencor, Inc. (Xencor) is a biotechnology company. The company develops antibody and protein therapeutics for the treatment of cancer and autoimmune inflammation. Its products include XmAb 5574 (MOR208) anti-CD19, XmAb 5871 anti-CD19/CD32b, XmAb 2513 anti-CD30, XmAb 7195 anti-IgE/CD32b, XmAb …
  • InfuSystem Holdings, Inc. (INFU):企業の財務及び戦略的SWOT分析
    Summary InfuSystem Holdings, Inc. (InfuSystem) is a healthcare service company that offers infusion pumps. The company provides ambulatory infusion pumps and associated clinical services to oncologists and their patients. Its patient services include InfuCare Help Hotline, InfuEase, education, and p …
  • Abdi Ibrahim Ilac Sanayi ve Ticaret A.S.:企業の戦略的SWOT分析
    Abdi Ibrahim Ilac Sanayi ve Ticaret A.S. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Xizang Haisco Pharmaceutical Group Co., Ltd. (002653):企業概要、財務及び戦略的SWOT分析
    Summary Xizang Haisco Pharmaceutical Group Co., Ltd. (Haisco Pharmaceutical) is a generic pharmaceutical company. The company’s product portfolio includes parenteral nutrition, first aid drugs, antibiotics, anesthetic agents, nervous systems, digestive systems, and tumor adjuvant products. It offers …
  • Key West Aloe Holdings, LLC:企業の戦略・SWOT・財務分析
    SummaryKey West Aloe Holdings, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Natera Inc (NTRA):企業のM&A・提携動向(医療分野)
    Summary Natera Inc (Natera), formerly Gene Security Network, Inc. is a biotechnology company that develops bioinformatics technologies to check small quantities of genetic material. The company’s products include panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genet …
  • Mirvac Group:企業の戦略・SWOT・財務分析
    SummaryMirvac Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Lojas Americanas S.A.:企業の戦略・SWOT・財務分析
    SummaryLojas Americanas S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • China Man-Made Fiber Corporation (1718):企業概要、財務及び戦略的SWOT分析
    Summary China Man-Made Fiber Corporation (CMFC) is a petrochemical manufacturer. The company offers products through categorizes such as petrochemical and fiber products. Its petrochemicals include mono-ethylene glycol, di-ethylene glycol, tri-ethylene glycol, ethylene oxide and nonyl-phenol. CMFC o …
  • K3 Business Technology Group plc (KBT):企業の財務及び戦略的SWOT分析
    Summary K3 Business Technology Group plc (K3 BTG) is an information technology service provider that supplies integrated business systems. The company offers products such as axis fashion, fresh dynamics, MS dynamics AX, MS dynamics NAV, pebblestone fashion, sage, and syspro. It provides services su …
  • Morphotek Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphotek Inc (Morphotek), a subsidiary of Eisai Co Ltd is a clinical-stage biotech company that develops novel classes of biological based products. The company offers a pipeline of monoclonal antibodies, antibody drug conjugates, and bispecific antibodies for the treatment of cancer, infla …
  • Turk Prysmian Kablo ve Sistemleri A.S. (PRKAB):企業概要、財務及び戦略的SWOT分析
    Summary Turk Prysmian Kablo ve Sistemleri A.S. (Turk Prysmian) is a cable manufacturing company. The company manufactures and markets cables and systems to energy and telecommunications industry. Its products include copper conductor communication cables, fiber optic cables, special cables and power …
  • ConSynance Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary ConSynance Therapeutics Inc (ConSynance Therapeutics) is a drug discovery company that concentrates on the development of new therapeutic solutions for unmet medical needs. The company’s pipeline programs include CSTI-100, CSTI-200, and CSTI-300 among others. It develops pipeline programs fo …
  • Matthews International Corporation (MATW):企業の財務及び戦略的SWOT分析
    Matthews International Corporation (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Praj Industries Ltd. (PRAJIND):企業財務及び戦略的SWOT分析
    Summary Praj Industries Ltd. (Praj) is an oil and gas company that develops, manufactures and markets biodiesel and ethanol. The company also provides brewery technology and waste-water treatment systems. It offers holistic solution to biofuel, bionutrient and brewery industry. Praj offers enginneri …
  • HeBei Jinniu Chemical Industry Co., Ltd. (600722):企業概要、財務及び戦略的SWOT分析
    Summary HeBei Jinniu Chemical Industry Co., Ltd. (Hebei Jinniu Chemical) is a chemical manufacturer. The company manufactures and markets PVC resin products. Its products include polyvinyl chloride (PVC) resins, caustic soda, hydrochloric acid, liquid chloride and cement. Hebei Jinniu Chemical’s PVC …
  • TV Sundram Iyengar and Sons Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TV Sundram Iyengar and Sons Lim …
  • MagForce Nanotechnologies AG (MF6):企業概要、財務及び戦略的SWOT分析
    Summary MagForce Nanotechnologies AG (MagForce) is a healthcare service provider. The company conducts research and development of nanotechnology-based cancer treatment. It offers products for treatment of solid tumors and cancer treatment. MagForce offers products such as NanoTherm therapy, NanoThe …
  • Hindustan ZInc Ltd:戦略・SWOT・企業財務分析
    Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report Summary Hindustan ZInc Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆